Loading…
Pyridostigmine Bromide Alters Locomotion and Thigmotaxis of Rats: Gender Effects
Male rats and female rats in the proestrous and metestrous stages of estrus were tested to determine the effects of pyridostigmine bromide on locomotion rate and thigmotactic response using doses of 3.0, 10.0, and 30.0 mg/kg. Thirty minutes after administration of the pyridostigmine bromide the rats...
Saved in:
Published in: | Pharmacology, biochemistry and behavior biochemistry and behavior, 1999-07, Vol.63 (3), p.401-406 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 406 |
container_issue | 3 |
container_start_page | 401 |
container_title | Pharmacology, biochemistry and behavior |
container_volume | 63 |
creator | Hoy, J.B Cody, B.A Karlix, J.L Schmidt, C.J Tebbett, I.R Toffollo, S Van Haaren, F Wielbo, D |
description | Male rats and female rats in the proestrous and metestrous stages of estrus were tested to determine the effects of pyridostigmine bromide on locomotion rate and thigmotactic response using doses of 3.0, 10.0, and 30.0 mg/kg. Thirty minutes after administration of the pyridostigmine bromide the rats were videorecorded for 2 h in a 1 m
2 open-field arena. The rats’ activities were analyzed for the drug’s effect on speed throughout the 2 h and during six 20-min segments. Also, the times that the rats were observed moving through the central 50% of the arena were determined. Locomotion rates decreased significantly, and thigmotaxses increased significantly in all groups of rats as a dose response to pyridostigmine bromide. Habituation occurred over 2 h for both responses, primarily during the first 40 min. Female rats were more affected than males, but metestrous and proestrous females did not differ significantly in their responses. At the 30 mg/kg the effect was persistent throughout the test period. Proestrous females dosed at 30 mg/kg had much higher pyridostigmine bromide serum levels than metestrous females and males. |
doi_str_mv | 10.1016/S0091-3057(99)00014-3 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_17500933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091305799000143</els_id><sourcerecordid>17500933</sourcerecordid><originalsourceid>FETCH-LOGICAL-e323t-504e1752beb13774e5b192904a6890d4683275b414ab07cfee6d62c318233c153</originalsourceid><addsrcrecordid>eNpF0UtLxDAUBeAgio6Pn6BkIaKLatKkTeNGVHzBgIOO65AmtxppG006ov_ezDjq6m4-Dpx7ENql5JgSWp48EiJpxkghDqU8IoRQnrEVNKKVYFlBhVhFoz-ygTZjfE2I56VYRxuU8OQqMkKTyVdw1sfBPXeuB3wRfOcs4PN2gBDx2Bvf-cH5Huve4ulLYn7Qny5i3-AHPcRTfAO9hYCvmgbMELfRWqPbCDvLu4Werq-ml7fZ-P7m7vJ8nAHL2ZAVhAMVRV5DTZkQHIqaylwSrstKEsvLiuWiqDnluibCNAClLXPDaJUzZmjBttDBT-5b8O8ziIPqXDTQtroHP4sqhaf6jCW4t4SzugOr3oLrdPhSvz9IYH8JdDS6bYLujYv_rqqoLHliZz8MUqsPB0FF46A3YF1IxZX1LmWq-ThqMY6af15JqRbjKMa-ATgcfkw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17500933</pqid></control><display><type>article</type><title>Pyridostigmine Bromide Alters Locomotion and Thigmotaxis of Rats: Gender Effects</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Hoy, J.B ; Cody, B.A ; Karlix, J.L ; Schmidt, C.J ; Tebbett, I.R ; Toffollo, S ; Van Haaren, F ; Wielbo, D</creator><creatorcontrib>Hoy, J.B ; Cody, B.A ; Karlix, J.L ; Schmidt, C.J ; Tebbett, I.R ; Toffollo, S ; Van Haaren, F ; Wielbo, D</creatorcontrib><description>Male rats and female rats in the proestrous and metestrous stages of estrus were tested to determine the effects of pyridostigmine bromide on locomotion rate and thigmotactic response using doses of 3.0, 10.0, and 30.0 mg/kg. Thirty minutes after administration of the pyridostigmine bromide the rats were videorecorded for 2 h in a 1 m
2 open-field arena. The rats’ activities were analyzed for the drug’s effect on speed throughout the 2 h and during six 20-min segments. Also, the times that the rats were observed moving through the central 50% of the arena were determined. Locomotion rates decreased significantly, and thigmotaxses increased significantly in all groups of rats as a dose response to pyridostigmine bromide. Habituation occurred over 2 h for both responses, primarily during the first 40 min. Female rats were more affected than males, but metestrous and proestrous females did not differ significantly in their responses. At the 30 mg/kg the effect was persistent throughout the test period. Proestrous females dosed at 30 mg/kg had much higher pyridostigmine bromide serum levels than metestrous females and males.</description><identifier>ISSN: 0091-3057</identifier><identifier>EISSN: 1873-5177</identifier><identifier>DOI: 10.1016/S0091-3057(99)00014-3</identifier><identifier>PMID: 10418780</identifier><identifier>CODEN: PBBHAU</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Animals ; Biological and medical sciences ; Cholinesterase Inhibitors - blood ; Cholinesterase Inhibitors - pharmacology ; DEET - pharmacology ; Drug Synergism ; Estrus - physiology ; Female ; Gender effect ; Insect Repellents - pharmacology ; Insecticides - pharmacology ; Locomotion ; Male ; Medical sciences ; Motor Activity - drug effects ; Muscle ; Open field ; Orientation - drug effects ; Permethrin ; Pharmacology. Drug treatments ; Physical Stimulation ; Pyrethrins - pharmacology ; Pyridostigmine bromide ; Pyridostigmine Bromide - blood ; Pyridostigmine Bromide - pharmacology ; Rats ; Rats, Sprague-Dawley ; Sex Characteristics ; Thigmotaxis</subject><ispartof>Pharmacology, biochemistry and behavior, 1999-07, Vol.63 (3), p.401-406</ispartof><rights>1999 Elsevier Science Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1881964$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10418780$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hoy, J.B</creatorcontrib><creatorcontrib>Cody, B.A</creatorcontrib><creatorcontrib>Karlix, J.L</creatorcontrib><creatorcontrib>Schmidt, C.J</creatorcontrib><creatorcontrib>Tebbett, I.R</creatorcontrib><creatorcontrib>Toffollo, S</creatorcontrib><creatorcontrib>Van Haaren, F</creatorcontrib><creatorcontrib>Wielbo, D</creatorcontrib><title>Pyridostigmine Bromide Alters Locomotion and Thigmotaxis of Rats: Gender Effects</title><title>Pharmacology, biochemistry and behavior</title><addtitle>Pharmacol Biochem Behav</addtitle><description>Male rats and female rats in the proestrous and metestrous stages of estrus were tested to determine the effects of pyridostigmine bromide on locomotion rate and thigmotactic response using doses of 3.0, 10.0, and 30.0 mg/kg. Thirty minutes after administration of the pyridostigmine bromide the rats were videorecorded for 2 h in a 1 m
2 open-field arena. The rats’ activities were analyzed for the drug’s effect on speed throughout the 2 h and during six 20-min segments. Also, the times that the rats were observed moving through the central 50% of the arena were determined. Locomotion rates decreased significantly, and thigmotaxses increased significantly in all groups of rats as a dose response to pyridostigmine bromide. Habituation occurred over 2 h for both responses, primarily during the first 40 min. Female rats were more affected than males, but metestrous and proestrous females did not differ significantly in their responses. At the 30 mg/kg the effect was persistent throughout the test period. Proestrous females dosed at 30 mg/kg had much higher pyridostigmine bromide serum levels than metestrous females and males.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cholinesterase Inhibitors - blood</subject><subject>Cholinesterase Inhibitors - pharmacology</subject><subject>DEET - pharmacology</subject><subject>Drug Synergism</subject><subject>Estrus - physiology</subject><subject>Female</subject><subject>Gender effect</subject><subject>Insect Repellents - pharmacology</subject><subject>Insecticides - pharmacology</subject><subject>Locomotion</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Motor Activity - drug effects</subject><subject>Muscle</subject><subject>Open field</subject><subject>Orientation - drug effects</subject><subject>Permethrin</subject><subject>Pharmacology. Drug treatments</subject><subject>Physical Stimulation</subject><subject>Pyrethrins - pharmacology</subject><subject>Pyridostigmine bromide</subject><subject>Pyridostigmine Bromide - blood</subject><subject>Pyridostigmine Bromide - pharmacology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Sex Characteristics</subject><subject>Thigmotaxis</subject><issn>0091-3057</issn><issn>1873-5177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNpF0UtLxDAUBeAgio6Pn6BkIaKLatKkTeNGVHzBgIOO65AmtxppG006ov_ezDjq6m4-Dpx7ENql5JgSWp48EiJpxkghDqU8IoRQnrEVNKKVYFlBhVhFoz-ygTZjfE2I56VYRxuU8OQqMkKTyVdw1sfBPXeuB3wRfOcs4PN2gBDx2Bvf-cH5Huve4ulLYn7Qny5i3-AHPcRTfAO9hYCvmgbMELfRWqPbCDvLu4Werq-ml7fZ-P7m7vJ8nAHL2ZAVhAMVRV5DTZkQHIqaylwSrstKEsvLiuWiqDnluibCNAClLXPDaJUzZmjBttDBT-5b8O8ziIPqXDTQtroHP4sqhaf6jCW4t4SzugOr3oLrdPhSvz9IYH8JdDS6bYLujYv_rqqoLHliZz8MUqsPB0FF46A3YF1IxZX1LmWq-ThqMY6af15JqRbjKMa-ATgcfkw</recordid><startdate>19990701</startdate><enddate>19990701</enddate><creator>Hoy, J.B</creator><creator>Cody, B.A</creator><creator>Karlix, J.L</creator><creator>Schmidt, C.J</creator><creator>Tebbett, I.R</creator><creator>Toffollo, S</creator><creator>Van Haaren, F</creator><creator>Wielbo, D</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QG</scope></search><sort><creationdate>19990701</creationdate><title>Pyridostigmine Bromide Alters Locomotion and Thigmotaxis of Rats: Gender Effects</title><author>Hoy, J.B ; Cody, B.A ; Karlix, J.L ; Schmidt, C.J ; Tebbett, I.R ; Toffollo, S ; Van Haaren, F ; Wielbo, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e323t-504e1752beb13774e5b192904a6890d4683275b414ab07cfee6d62c318233c153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cholinesterase Inhibitors - blood</topic><topic>Cholinesterase Inhibitors - pharmacology</topic><topic>DEET - pharmacology</topic><topic>Drug Synergism</topic><topic>Estrus - physiology</topic><topic>Female</topic><topic>Gender effect</topic><topic>Insect Repellents - pharmacology</topic><topic>Insecticides - pharmacology</topic><topic>Locomotion</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Motor Activity - drug effects</topic><topic>Muscle</topic><topic>Open field</topic><topic>Orientation - drug effects</topic><topic>Permethrin</topic><topic>Pharmacology. Drug treatments</topic><topic>Physical Stimulation</topic><topic>Pyrethrins - pharmacology</topic><topic>Pyridostigmine bromide</topic><topic>Pyridostigmine Bromide - blood</topic><topic>Pyridostigmine Bromide - pharmacology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Sex Characteristics</topic><topic>Thigmotaxis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hoy, J.B</creatorcontrib><creatorcontrib>Cody, B.A</creatorcontrib><creatorcontrib>Karlix, J.L</creatorcontrib><creatorcontrib>Schmidt, C.J</creatorcontrib><creatorcontrib>Tebbett, I.R</creatorcontrib><creatorcontrib>Toffollo, S</creatorcontrib><creatorcontrib>Van Haaren, F</creatorcontrib><creatorcontrib>Wielbo, D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Animal Behavior Abstracts</collection><jtitle>Pharmacology, biochemistry and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hoy, J.B</au><au>Cody, B.A</au><au>Karlix, J.L</au><au>Schmidt, C.J</au><au>Tebbett, I.R</au><au>Toffollo, S</au><au>Van Haaren, F</au><au>Wielbo, D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pyridostigmine Bromide Alters Locomotion and Thigmotaxis of Rats: Gender Effects</atitle><jtitle>Pharmacology, biochemistry and behavior</jtitle><addtitle>Pharmacol Biochem Behav</addtitle><date>1999-07-01</date><risdate>1999</risdate><volume>63</volume><issue>3</issue><spage>401</spage><epage>406</epage><pages>401-406</pages><issn>0091-3057</issn><eissn>1873-5177</eissn><coden>PBBHAU</coden><abstract>Male rats and female rats in the proestrous and metestrous stages of estrus were tested to determine the effects of pyridostigmine bromide on locomotion rate and thigmotactic response using doses of 3.0, 10.0, and 30.0 mg/kg. Thirty minutes after administration of the pyridostigmine bromide the rats were videorecorded for 2 h in a 1 m
2 open-field arena. The rats’ activities were analyzed for the drug’s effect on speed throughout the 2 h and during six 20-min segments. Also, the times that the rats were observed moving through the central 50% of the arena were determined. Locomotion rates decreased significantly, and thigmotaxses increased significantly in all groups of rats as a dose response to pyridostigmine bromide. Habituation occurred over 2 h for both responses, primarily during the first 40 min. Female rats were more affected than males, but metestrous and proestrous females did not differ significantly in their responses. At the 30 mg/kg the effect was persistent throughout the test period. Proestrous females dosed at 30 mg/kg had much higher pyridostigmine bromide serum levels than metestrous females and males.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>10418780</pmid><doi>10.1016/S0091-3057(99)00014-3</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0091-3057 |
ispartof | Pharmacology, biochemistry and behavior, 1999-07, Vol.63 (3), p.401-406 |
issn | 0091-3057 1873-5177 |
language | eng |
recordid | cdi_proquest_miscellaneous_17500933 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Animals Biological and medical sciences Cholinesterase Inhibitors - blood Cholinesterase Inhibitors - pharmacology DEET - pharmacology Drug Synergism Estrus - physiology Female Gender effect Insect Repellents - pharmacology Insecticides - pharmacology Locomotion Male Medical sciences Motor Activity - drug effects Muscle Open field Orientation - drug effects Permethrin Pharmacology. Drug treatments Physical Stimulation Pyrethrins - pharmacology Pyridostigmine bromide Pyridostigmine Bromide - blood Pyridostigmine Bromide - pharmacology Rats Rats, Sprague-Dawley Sex Characteristics Thigmotaxis |
title | Pyridostigmine Bromide Alters Locomotion and Thigmotaxis of Rats: Gender Effects |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A21%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pyridostigmine%20Bromide%20Alters%20Locomotion%20and%20Thigmotaxis%20of%20Rats:%20Gender%20Effects&rft.jtitle=Pharmacology,%20biochemistry%20and%20behavior&rft.au=Hoy,%20J.B&rft.date=1999-07-01&rft.volume=63&rft.issue=3&rft.spage=401&rft.epage=406&rft.pages=401-406&rft.issn=0091-3057&rft.eissn=1873-5177&rft.coden=PBBHAU&rft_id=info:doi/10.1016/S0091-3057(99)00014-3&rft_dat=%3Cproquest_pubme%3E17500933%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-e323t-504e1752beb13774e5b192904a6890d4683275b414ab07cfee6d62c318233c153%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17500933&rft_id=info:pmid/10418780&rfr_iscdi=true |